Navigation Links
Effect of reducing blood pressure with medications immediately following ischemic stroke
Date:11/17/2013

Chicago Jiang He, M.D., Ph.D., of the Tulane University School of Public Health and Tropical Medicine, New Orleans, and colleagues examined whether moderate lowering of blood pressure within the first 48 hours after the onset of an acute ischemic stroke would reduce death and major disability at 14 days or hospital discharge.

"Stroke is the second leading cause of death and the leading cause of serious, long-term disability worldwide. Clinical trials have documented that lowering blood pressure reduces the risk of stroke in hypertensive and normotensive patients with a history of stroke or transient ischemic attack. Although the benefit of lowering blood pressure for primary and secondary prevention of stroke has been established, the effect of immediate antihypertensive treatment in patients with acute ischemic stroke and elevated blood pressure is uncertain," according to background information in the article.

The China Antihypertensive Trial in Acute Ischemic Stroke, a randomized controlled trial, was conducted among 4,071 patients with ischemic stroke within 48 hours of symptom onset and elevated systolic blood pressure. Patients were recruited from 26 hospitals across China between August 2009 and May 2013. Patients (n = 2,038) were assigned to receive antihypertensive treatment (aimed at lowering systolic blood pressure by 10 percent to 25 percent within the first 24 hours after randomization, achieving blood pressure less than 140/90 mm Hg within 7 days, and maintaining this level during hospitalization) or to discontinue all antihypertensive medications (control) during hospitalization (n = 2,033).

Average systolic blood pressure was reduced from 166.7 mm Hg to 144.7 mm Hg (-12.7 percent) within 24 hours in the antihypertensive treatment group and from 165.6 mm Hg to 152.9 mm Hg (-7.2 percent) in the control group within 24 hours after randomization. Average systolic blood pressure was 137.3 mm Hg in the antihypertensive treatment group and 146.5 mm Hg in the control group at day 7 after randomization. The primary outcome (a combination of death and major disability at 14 days or hospital discharge) did not differ between treatment groups (683 events [antihypertensive treatment] vs. 681 events [control]) at 14 days or hospital discharge. The secondary composite outcome of death and major disability at 3-month posttreatment follow-up did not differ between treatment groups.

These findings suggest that the decision to lower blood pressure with antihypertensive treatment in patients with acute ischemic stroke does not improve or worsen outcome and therefore should be based on individual clinical judgment, the authors write.


'/>"/>

Contact: Arthur Nead
anead@tulane.edu
504-247-1443
The JAMA Network Journals
Source:Eurekalert

Related medicine news :

1. Study examines effectiveness, safety of transcatheter aortic valve replacement in US
2. Discover An Effective Skin Care Business Plan With The “Skin Care Tycoon” Course – Vinamy
3. Discover A Safe And Effective Diabetic Peripheral Neuropathy Treatment With The “Peripheral Neuropathy Solution” Program – Vinamy
4. Discover an Effective Eating Plan to Gain Muscle Mass Fast With the “How Much Protein” Program – Vkoolelite
5. The Natural Cure for HPV Review Discloses Andrea Segovia's New Effective HPV Remedy
6. Exercise training is effective as prehabilitation before surgery in an elderly population
7. Wartrol: the Natural and Effective Genital Warts Relief Solution Now Available in the Market with 1 Extra Bottle Offer
8. 50% Off Exciting One-Day Sale on Face Whisperer® Night Cream from Sublime Beauty®; Rare Sale for the Effective Anti-Aging Serum
9. Asbestos Found in Winnebago County Jail, Florida Asbestos Testing Company AGC Environmental Offers Tip How to Avoid the Mineral Fiber's Fatal Health Effects
10. Cutting edge research into drug side effects could save NHS money and make more drugs safely available
11. Dr. Oz Show Discusses Long-term Side Effects of LASIK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2020)... LAUREL, N.J. (PRWEB) , ... May 27, 2020 ... ... contract manufacturer, announces that it is now manufacturing face shields to be ... novel coronavirus that causes COVID-19. These face shields are single use, made to ...
(Date:5/27/2020)... ... May 27, 2020 , ... ... of Washington Professor of Bioengineering, Founder & Editor of scientific journal WATER, ... ( https://www.amazon.com/Fourth-Phase-Water-Beyond-Liquid-ebook/dp/B00N2ASKF2 ) , https://www.voiceamerica.com/episode/123059/the-fourth-phase-of-water , * , During ...
(Date:5/26/2020)... ... , ... Today TRC Companies (“ TRC ”) announced the release of its ... owners and leaders assess whether their organizations are prepared to move forward as the ... intended to assist business leaders evaluate their readiness relative to CDC guidance and provides ...
(Date:5/25/2020)... ... ... Winemaker Grant Long Jr. is introducing three Toilet Paper Reserve wines. “These are ... complicated times,” he said, in announcing the new wines. The wines are 2019 Chardonnay ... Wine Blend are sourced in the Napa Valley; the Grenache comes from the El ...
(Date:5/21/2020)... Minn. (PRWEB) , ... May 21, 2020 , ... ... medical device manufacturer, announces its first milestone to deliver over one million FDA-compliant ... eight weeks. Summit Medical Face Shields meet the critical need for personal protective ...
Breaking Medicine News(10 mins):
(Date:5/21/2020)... ... May 21, 2020 , ... ... needs in the field of urology, today announced that Naveen Divakaruni, D.O., Advocate ... Excellence. The designation recognizes that Dr. Divakaruni has achieved a high level of ...
(Date:5/21/2020)... ... ... Labyrinthe Labs has announced the launch of its brand new and ground-breaking ... for fast-action relief of joint and muscle soreness, Lefa is botanically powered by a ... and muscles. , According to the National Institutes of Health , approximately ...
(Date:5/17/2020)... ... 2020 , ... The Sea Cucumber-derived triterpenoid glycoside Frondoside A, which has been ... the Sea Cucumber in a proprietary process to give SeaCare Dietary Supplement ... and time again: “You get what you pay for.” It is usually in reference ...
Breaking Medicine Technology: